These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

864 related articles for article (PubMed ID: 19387235)

  • 21. Refractive and corneal aberrometric changes after intracorneal ring implantation in corneas with pellucid marginal degeneration.
    Piñero DP; Alio JL; Morbelli H; Uceda-Montanes A; El Kady B; Coskunseven E; Pascual I
    Ophthalmology; 2009 Sep; 116(9):1656-64. PubMed ID: 19643482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
    Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
    J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term outcome in ocular intractable surface disease with Seoul-type keratoprosthesis.
    Kim MK; Lee SM; Lee JL; Chung TY; Kim YH; Wee WR; Lee JH
    Cornea; 2007 Jun; 26(5):546-51. PubMed ID: 17525649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glaucoma associated with keratoprosthesis.
    Netland PA; Terada H; Dohlman CH
    Ophthalmology; 1998 Apr; 105(4):751-7. PubMed ID: 9544652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medium-term outcomes of boston type 1 keratoprosthesis implantation in Bangkok, Thailand.
    Lekhanont K; Thaweesit P; Muntham D; Chuckpaiwong V; Vongthongsri A
    Cornea; 2014 Dec; 33(12):1312-9. PubMed ID: 25285588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of the Boston keratoprosthesis.
    Ament JD; Stryjewski TP; Ciolino JB; Todani A; Chodosh J; Dohlman CH
    Am J Ophthalmol; 2010 Feb; 149(2):221-228.e2. PubMed ID: 19939347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glaucoma in eyes with severe chemical burn, before and after keratoprosthesis.
    Cade F; Grosskreutz CL; Tauber A; Dohlman CH
    Cornea; 2011 Dec; 30(12):1322-7. PubMed ID: 22001817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infectious endophthalmitis in adult eyes receiving Boston type I keratoprosthesis.
    Ramchandran RS; Diloreto DA; Chung MM; Kleinman DM; Plotnik RP; Graman P; Aquavella JV
    Ophthalmology; 2012 Apr; 119(4):674-81. PubMed ID: 22266108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Boston keratoprosthesis type I in mucous membrane pemphigoid.
    Palioura S; Kim B; Dohlman CH; Chodosh J
    Cornea; 2013 Jul; 32(7):956-61. PubMed ID: 23538625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracorneal ring segment implantation in corneas with post-laser in situ keratomileusis keratectasia.
    Piñero DP; Alio JL; Uceda-Montanes A; El Kady B; Pascual I
    Ophthalmology; 2009 Sep; 116(9):1665-74. PubMed ID: 19643485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glaucoma and keratoprosthesis surgery: role of adjunctive cyclophotocoagulation.
    Rivier D; Paula JS; Kim E; Dohlman CH; Grosskreutz CL
    J Glaucoma; 2009; 18(4):321-4. PubMed ID: 19365199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of precut, γ-irradiated corneal lenticules in Boston type 1 keratoprosthesis implantation.
    Akpek EK; Aldave AJ; Aquavella JV
    Am J Ophthalmol; 2012 Sep; 154(3):495-498.e1. PubMed ID: 22633353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.